image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SigmaRoc - Record acquisition enhances FY’25 and FY’26 eps 18% and 25%, dropping PE to 5.3 and 4.6

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 56p
A shell is usually a company that has fallen on hard times to the extent that its main value lies in having a stock market listing. A skilful and well-connected management team, especially if it has the 'placing power' of a powerful stockbroker or merchant bank behind it, can work wonders with a shell. In the case of London-listed SigmaRoc, the business was founded  seven years ago when a trio of former LafargeHolcim senior executives and entrepreneurs alighted on a moribund cash shell, Messaging International, and relaunched it as a buy-and-build construction materials company. Co-founder CEO Max Vermorken, a financier, and Chairman David Barrett, known for transforming London Concrete in the late 90s from a single plant to over ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author